Results 91 to 100 of about 20,498,806 (233)

Impact of tissue heterogeneity on intracranial Cesium‐131 brachytherapy dosimetry: A patient‐specific Monte Carlo Study

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Abstract Background AAPM TG‐43‐based dose calculations for intracranial cesium‐131 (131Cs) brachytherapy ignore patient‐specific heterogeneities, which can affect dose accuracy. This study investigates the dosimetric impact of these heterogeneity effects using Monte Carlo (MC) simulations and patient‐specific imaging data.
Tirthraj Adhikari   +6 more
wiley   +1 more source

Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpasa experience

open access: yes, 2003
Purpose: To evaluate the results and complications of treatment with high dose rate (HDR) compared to low dose rate (LDR) brachytherapy in cervical ...
Atkovar, G   +9 more
core   +1 more source

Salvage high-dose-rate brachytherapy for local recurrence of prostate cancer

open access: yes, 2020
The article describes a successful experience of using high-dose rate brachytherapy (192Ir) in patients with local recurrence of hormone-resistant prostate cancer.
Yagudaev D.M.   +4 more
core   +2 more sources

Development of a low‐cost 3D‐printed phantom for end‐to‐end testing of model‐based dose calculation algorithms (MBDCAs) in high‐dose‐rate (HDR) brachytherapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Abstract Background Model‐Based Dose Calculation Algorithms (MBDCAs), such as AcurosBV, have improved dosimetric accuracy in high‐dose‐rate (HDR) brachytherapy by accounting for medium heterogeneities and variations in scatter conditions. However, their safe and effective clinical implementation requires thorough commissioning, of which end‐to‐end (E2E)
Sean Grace   +3 more
wiley   +1 more source

Automated verification of source dwell position in lunar ovoid applicators

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Abstract Background Accurate reconstruction of the source dwell positions in high‐dose‐rate (HDR) brachytherapy is essential for treatment quality. The Venezia™ gynaecological applicator, with its lunar‐shaped ovoids, poses challenges because conventional dummy markers do not match the actual source path, introducing systematic uncertainties.
Miquel Gubau‐Besalú   +6 more
wiley   +1 more source

Fricke gel-layer dosimetry in high dose-rate brachytherapy

open access: yes, 2010
The aim of this study was to evaluate the reliability of Fricke gel-layer dosimeters for the measurement of in-phantom dose distributions produced by a 192Ir brachytherapy source.
A. Negri   +3 more
core   +1 more source

Use of ultrasound in image-guided high-dose-rate brachytherapy: enumerations and arguments

open access: yesJournal of Contemporary Brachytherapy, 2017
Inherently, brachytherapy is the most conformal radiotherapeutic technique. As an aid to brachytherapy, ultrasonography (USG) serves as a portable, inexpensive, and simple to use method allowing for accurate, reproducible, and adaptive treatments.
Susovan Banerjee   +6 more
doaj   +1 more source

High dose-rate brachytherapy in the treatment of prostate cancer

open access: yesTranslational Andrology and Urology, 2018
High dose-rate (HDR) brachytherapy involves delivery of a high dose of radiation to the cancer with great sparing of surrounding organs at risk. Prostate cancer is thought to be particularly sensitive to radiation delivered at high dose-rate or at high dose per fraction.
Mendez, Lucas C., Morton, Gerard C.
openaire   +2 more sources

Carcinoma In Situ Skip Lesions of the Uterine Corpus in Cervical Squamous Cell Carcinoma: Impact on Target Setting in Radiotherapy

open access: yesCancer Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background In definitive radiotherapy for FIGO Stage I–III cervical cancer, external beam radiotherapy and/or brachytherapy are used—alone or in combination with concurrent chemotherapy depending on stage—with target delineation largely guided by clinically apparent disease.
Mayumi Harada   +12 more
wiley   +1 more source

High-dose-rate interstitial brachytherapy in early stage oral tongue cancer – 15 year experience from a tertiary care institute

open access: yes, 2016
Purpose: To determine outcomes of interstitial high-dose-rate brachytherapy (HDR-BT) in patients with early stage oral tongue cancer. Material and methods : Ninety-two patients with stage I and II oral tongue cancer were treated with HDR-BT between ...
Sushmita Ghoshal   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy